Boston Scientific acquisition of BTG : US medical devices manufacturer Boston Scientific has wrapped up its previously announced $4.2 billion acquisition of UK-based healthcare company BTG. In November 2018, Boston Scientific reached an agreement on the terms of a recommended offer to acquire the British healthcare company for a cash consideration of 840 pence per […]
Continue reading …Laboratory-grown red blood cells could help study malaria invasion, say researchers
August 30, 2019 No Comment
Scientists at the University of Bristol and Imperial College London, UK, have developed a new research system to study how malaria parasites invade red blood cells using laboratory-grown red blood cells. Funded by the National Institute for Health Research (NIHR) and NHS Blood and Transplant, the new tool will identify key host proteins and their domains involved in […]
Continue reading …Mereo BioPharma begins BPS-804 mid-stage trial in osteogenesis imperfecta
October 30, 2018 No Comment
British specialty biopharma company Mereo BioPharma Group has wrapped up enrollment of patients for a phase 2b clinical trial that will evaluate its human monoclonal antibody BPS-804 (Setrusumab) as a potential treatment option for osteogenesis imperfecta (OI), better known as the brittle bone disease. Osteogenesis imperfecta is a rare, chronic genetic disorder that makes bones […]
Continue reading …
Evox Therapeutics, an Oxford biotech spinout focused on developing exosome therapeutics, has raised £35.5 million from a Series B financing round led by Redmile Group with new investments from Google’s GV, Cowen Healthcare Investments and others. The Series B round of the UK biotechnology company also saw participation from existing investors – Oxford Sciences Innovation […]
Continue reading …
Orchard Therapeutics, a UK and US based gene therapy company, has secured $150 million of new capital through a Series C funding round, towards advancing its gene therapies for rare diseases. Deerfield Management led the Series C round with other firms like RA Capital Management, Perceptive Advisors, Venrock and Foresite Capital making new investments in […]
Continue reading …
Phase 3 trial for apomorphine infusion : British pharma company Britannia Pharmaceuticals said that its APO-go/MOVAPO (apomorphine) subcutaneous infusion has succeeded in a phase 3 trial called TOLEDO by delivering effective relief of persistent motor fluctuations in Parkinson’s disease. The TOLEDO trial saw apomorphine infusion given for 12 weeks in 107 Parkinson’s disease patients whose […]
Continue reading …
Update on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the approval of AstraZeneca lung cancer drug Imfinzi (durvalumab) for the treatment of locally-advanced, unresectable non-small cell lung cancer (NSCLC). The committee has recommended Imfinzi EMA approval of […]
Continue reading …
Business News Today
- Chinese lifestyle product retailer MINISO opens new store in Madrid
- Unilever to acquire Los Angeles-based SmartyPants Vitamins
- Bega Cheese to acquire Lion Dairy & Drinks for $412m
- Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
- TEXRail extension project : Trinity Metro selects AECOM as project consultant
- Castle Mountain Gold Mine California : Equinox Gold achieves commercial production
- McCormick to acquire Mexican hot sauce brand Cholula Hot Sauce
- Elliott Advisors offers to take over Swiss food company Aryzta for CHF0.8 per share
- US challenger bank Current raises $131m in Series C round
- HelloFresh to acquire US meal delivery service provider Factor75
